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Abstract
Objectives: The epidemiology of invasive Haemophilus influenzae (Hi) has changed since the introduction of the Hi type b
(Hib) vaccine. The aim of this study was to analyze the clinical and molecular epidemiology of Hi invasive disease in adults.
Methods: Clinical data of the 82 patients with Hi invasive infections were analyzed. Antimicrobial susceptibility, serotyping,
and genotyping were studied (2008–2013).
Results: Men accounted for 63.4% of patients (whose mean age was 64.3 years). The most frequent comorbidities were
immunosuppressive therapy (34.1%), malignancy (31.7%), diabetes, and COPD (both 22%). The 30-day mortality rate was
20.7%. The majority of the strains (84.3%) were nontypeable (NTHi) and serotype f was the most prevalent serotype in the
capsulated strains. The highest antimicrobial resistance was for cotrimoxazole (27.1%) and ampicillin (14.3%). Twenty-three
isolates (32.9%) had amino acid changes in the PBP3 involved in resistance. Capsulated strains were clonal and belonged to
clonal complexes 6 (serotype b), 124 (serotype f), and 18 (serotype e), whereas NTHi were genetically diverse.
Conclusions: Invasive Hi disease occurred mainly in elderly and those with underlying conditions, and it was associated with
a high mortality rate. NTHi were the most common cause of invasive disease and showed high genetic diversity.
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Introduction
Haemophilus influenzae is a human-restricted pathogen that
forms part of the normal nasopharyngeal microbiota. The
presence or absence of a polysaccharide capsule divides this
bacterium into two different groups [1,2]. The variability of
capsular polysaccharide means that encapsulated H. influenzae
strains are classified into six serotypes, labeled a–f. Before the
introduction of the conjugate vaccine against H. influenzae type b
(Hib), Hib was the major serotype responsible for invasive
infections in infants and young children, with meningoencephalitis
as the most common clinical manifestation [1,3,4]. With the
prevention provided by vaccination, colonization rates and
invasive infections in children have been considerably reduced
[1,3–6]. Non-capsulated strains, also known as nontypeable H.
influenzae (NTHi), frequently cause respiratory infections such as
otitis media in children and exacerbations of chronic respiratory
diseases and community-acquired pneumonia in fragile adult
populations [1,2,7–9]. Notably, since introduction of the Hib
vaccine a strain replacement has been observed in invasive
infections and nontypeable strains have become predominant
among cases of invasive H. influenzae disease in adults [10,11].
The main aims of this study were to analyze the demographic
and clinical characteristics of adult patients with invasive H.
influenzae infections and to determine the antimicrobial resistance
and molecular epidemiology of these invasive strains.
Materials and Methods
Ethical Statement
This study has been revised and approved for its publication by
the Clinical Research Ethics Committee of Bellvitge University
Hospital (PR223/14). Written informed consent was considered
not necessary for the study, as it was a retrospective analysis of our
usual everyday work. The data of the patients were anonymized
for the purposes of this analysis. The confidential information of
the patients was protected according to national normative.
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Study design and clinical data
A six-year laboratory-based study (2008–2013) was conducted
at the Bellvitge University Hospital, a tertiary care center for adult
patients located in the south of Barcelona (Spain), the aim being to
analyze the epidemiology of invasive H. influenzae. Invasive H.
influenzae were defined as the isolation of Hi from blood,
cerebrospinal fluid (CSF), or pleural fluid with clinical symptoms
in the patient. The denominator used to estimate incidence was
the number of persons by age group per year recorded in the
public database hosted on the website of the Official Statistics
Office of Catalonia (http://www.idescat.cat). Clinical and demo-
graphical data were retrieved from a prospective protocol of
bacteremia cases recorded at our institution; in those patients
without bacteremia their clinical records were reviewed.
Bacterial Strains
Invasive H. influenzae strains collected from sterile sites in our
laboratory were stored at 280uC. Isolates were identified by mass
spectrometry using a MALDI-TOF Biotyper version 3.0 (Bruker).
Differentiation between H. influenzae and H. haemolyticus was
performed by the detection of fucK, iga, and lgtC genes, using a
previously described methodology [12]. Isolates with a positive
detection for all three genes were considered H. influenzae.
Capsule Typing and Antimicrobial Susceptibility Testing
Capsular serotype was determined by PCR using primers and
conditions described elsewhere [13]. Antimicrobial susceptibility
was tested in all 82 isolates by disk diffusion as a part of the normal
laboratory routine, following CLSI recommendations. In the 70
available isolates, minimal inhibitory concentration (MIC) was
tested by the microdilution method using commercial panels
(STRHAE2; Sensititre, West Sussex, England) and following
Clinical Laboratory Standards Institute (CLSI) recommendations
[14,15]. b-lactamase activity was screened using the chromogenic
cephalosporin method (nitrocefin disks, BD, Madrid, Spain).
Identification of b-lactamase type was performed by PCR on all
the positive b-lactamase isolates using previously described primers
and conditions [16].
PPB3 Sequencing and Genotype Definition for Ampicillin
Resistance
An internal region of the ftsI gene (796-1741 pb) was amplified
by PCR and sequenced as previously described [17]. In
accordance with previous descriptions [18,19], H. influenzae
were classified into four ampicillin-resistant genotypes: b-lacta-
mase negative ampicillin susceptible (gBLNAS), strains without a
detectable resistance mechanism; b-lactamase negative ampicillin
resistant (gBLNAR), strains which presented mutations in the ftsI
gene; b-lactamase positive ampicillin resistant (gBLPAR), strains
producing b-lactamase; and b-lactamase positive amoxicillin/
clavulanic acid resistant (gBLPACR), strains which presented both
resistance mechanisms (b-lactamase production and mutations in
the ftsI gene).
Molecular Typing
Genomic DNA was digested with SmaI and the fragments were
separated by pulsed-field gel electrophoresis (PFGE), as reported
previously [9]. PFGE band patterns were analyzed using the
Fingerprinting II Software 3.0 (BioRad). The similarity of the
PFGE banding patterns was estimated with the Dice coefficient,
setting the optimization and tolerance at 1%. Isolates with $80%
relatedness were considered highly genetically related [20].
Multilocus sequence typing (MLST) was performed by DNA
sequencing of internal fragments of seven housekeeping genes
(adk, atpG, frdB, fuck, mdh, pgi, and recA), as previously described
[21]. Allele number and sequence types (ST) were assigned using
the H. influenzae MLST website (http://haemophilus.mlst.net).
Statistical Analyses
Statistical analyses were performed using GraphPad Prism
version 4, using Chi-square or Fisher’s exact tests, when
appropriate, with P,.05 being considered significant.
Results
Clinical characteristics
During the period 2008 to 2013 a total of 3433 H. influenzae
were isolated from adult patients in our hospital. Of these, 82
isolates (2.4%) caused invasive H. influenzae infection in 82
patients. The overall incidence for Hi invasive disease among
adults in our area during the study period was 2.12 episodes per
100,000 population. By age group the incidence of invasive disease
was higher among those aged 65 or older than among people #64
years (6.8/100,000 vs. 1.1/100,000; p,0.01). We observed no
significant change in the incidence of invasive disease over the
study period, neither overall nor by age group or serotype.
Table 1 shows the demographics, clinical characteristics, and
underlying conditions for the 82 patients with invasive H.
Figure 1. Distribution of 82 invasive H. influenzae isolated from adult patients (2008–2013). White bar: nontypeable H. influenzae. Black
bar: H. influenzae serotype f. Dotted bar: no available isolated for serotyping. Grey bar: H. influenzae serotype b. Lined bar: H. influenzae serotype e.
doi:10.1371/journal.pone.0112711.g001
Invasive Diseases Due to H. influenzae
PLOS ONE | www.plosone.org 2 November 2014 | Volume 9 | Issue 11 | e112711
influenzae infection. Fifty-two (63.1%) cases occurred in men and
the mean age of patients was 64.3 years. Most cases were
community-acquired, and pneumonia was the most frequent type
of infection (59.8%) The most common comorbidities were
immunosuppressive conditions, malignancies, diabetes, chronic
obstructive pulmonary disease (COPD), and heart disease
(Table 1). In general, older patients had higher rates of underlying
conditions than did those #64 years, especially for COPD (34.0%
vs. 5.7%, p = 0.002) and heart disease (27.6% vs. 5.7%, p = 0.018).
The 30-day mortality was 20.7% (n = 17), with no differences
between younger and older adults (p = 0.58).
Invasive H. influenzae: sample origin and serotypes
The source of strains in the 82 invasive Hi cases was: blood
(n = 70), CSF (n = 3), pleural fluid (n = 2), blood plus CSF (n = 5),
and blood plus pleural fluid (n = 2). Serotypes of isolates causing
meningitis were NTHi (n = 6) and Hif (n = 1), with one isolate
being unavailable (n = 1).
Unfortunately, only isolates from 70 cases (70/82, 85.37%) were
viable and available for microbiological studies. The majority of
these isolates were NTHi (n = 59, 84.3%), and the frequency of
capsulated isolates was low (n = 11, 15.7%). Among 11 capsulated
strains, 9 were serotype f (Hif), 1 serotype b (Hib), and 1 serotype e
(Hie) (Figure 1). Encapsulated H. influenzae were mainly isolated
from blood (n = 9, 81.8%). Both Hib and Hie strains were isolated
from patients with pneumonia. The foci of infection of Hif cases
were pneumonia (n = 3), epiglottitis (n = 1), meningitis (n = 1),
peritonitis (n = 1), facial cellulites (n = 1), and biliary tract infection
(n = 1).
Antimicrobial susceptibility
All 82 isolates tested by disk diffusion presented fully suscep-
tibility to amoxicillin/clavulanic acid, cefotaxime, ceftriaxone,
chloramphenicol, tetracycline, and ciprofloxacin. On the other
hand, 23% of the isolates (n = 19) were resistant to cotrimoxazole
and 8.5% (n = 7) were resistant to ampicillin due to b-lactamase
Table 1. Demographic data, clinical characteristics, and underlying conditions of 82 patients with an invasive H. influenzae episode
during the period 2008–2013.
Patients (n=82)
Characteristics [no. (%)]
Age (mean 6 SD); range 64.3616.1; 21–96
Male sex 52 (63.4)
Acquisition
Community-acquired 71 (86.6)
Hospital-acquired 11 (13.4)
Source of infection
Pneumonia/empyema 49 (59.8)
Meningitis 9 (11.0)
Biliary tract infection 9 (11.0)
Primary bacteremia 7 (8.5)
Epiglottitis 2 (2.4)
Othersa 6 (7.3)
Underlying conditions [no. (%)]
Immunosuppressive therapy 28 (34.1)
Solid organ malignancy 26 (31.7)
Diabetes 18 (22.0)
COPD 18 (22.0)
Heart disease 15 (18.3)
Chronic liver disease 11 (13.4)
Hematologic malignancyb 9 (11.0)
Cerebrovascular disease 5 (6.1)
Organ transplantc 4 (4.9)
HIV 2 (2.4)
Othersd 10 (12.2)
Shock 18 (22.0)
Neutropenia 8 (9.8)
Mortality
,30 days 17 (20.7)
aFacial cellulites, endometritis, liver abscess, and urinary-tract infection (n = 1, 1.2% each), and peritonitis (n = 2, 2.4%).
bLeukemia (n = 3, 3.6%), lymphoma (n = 1, 1.2%), and myeloma (n = 5, 6.1%).
cBone marrow transplant (n = 1, 1.2%), kidney transplant (n = 1, 1.2%), and liver transplantation (n = 2, 2.4%).
dCerebrospinal fluid fistula (n = 2, 2.4%), renal failure, autoimmune disease, and head trauma (n = 1, 1.2% each).
doi:10.1371/journal.pone.0112711.t001
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production. Antimicrobial susceptibility of the 70 available isolates
was tested by microdilution. All tested isolates were fully
susceptible to amoxicillin/clavulanic acid, cefepime, cefotaxime,
ceftriaxone, imipenem, chloramphenicol, tetracycline, and cipro-
floxacin (Table 2). Capsulated isolates were fully susceptible to all
tested antibiotics, with the exception of one strain that was
resistant to rifampin. By contrast, NTHi isolates presented higher
resistance rates to cotrimoxazole (27.1%), azithromycin (1.4%),
and cefuroxime (1.4%) (Table 2). Seven NTHi isolates (10%) were
ampicillin resistant: six (6/70, 8.6%) due to b-lactamase produc-
tion (MIC.4 mg/L) and one due to a modified PBP3
(MIC = 4 mg/L). In addition, three strains (3/70, 4.3%) presented
reduced ampicillin susceptibility (MIC = 2 mg/L). All six b-
lactamase producers presented the blaTEM-1 gene.
In order to determine the mutations in PBP3 the transpeptidase
domain of the ftsI gene was sequenced in all the isolates. Thirty-
four isolates (48.6%) presented mutations in the ftsI gene
(Table 3). The observed mutations allow us to classify the strains
into groups I and II, in accordance with Dabernat et al. [17]. The
most frequent substitutions were those which were classified as
group II (22/34, 64.7%). No isolates were observed in subgroup
IId or in groups III and III-like. Additionally, eight isolates (23.5%)
presented mutations in the ftsI gene, none of which were at the
positions which defined the groups. For this reason, they were
considered gBLNAS and classified into the miscellaneous group.
All these eight isolates presented similar ampicillin MIC to
susceptible strains (#0.5 mg/L), suggesting that these mutations
were not involved in decreased b-lactam susceptibility (Table 3).
Molecular epidemiology
Molecular typing by PFGE revealed 50 different patterns.
Fourteen clusters grouped between two and seven related isolates,
and 36 patterns were genotypically unique. Hif isolates were
grouped into two related clusters, one with seven isolates and the
other with two. The other 12 clusters grouped two NTHi isolates
each.
Molecular typing by MLST showed high genetic variability
among 59 NTHi isolates, which had 51 different sequence types
(STs). After eBURST analysis, NTHi STs were distributed into
three clonal groups, along with 45 singletons. Clonal group 1
grouped ST103 and ST134, with one isolate each. Group 2 was
formed by three isolates, with ST3 (n = 1) and ST367 (n = 2).
Finally, clonal group 3 comprised ST14 (n = 1) and a single locus
variant (SLV, n = 1). Among the 45 singletons the most frequent
ST was ST57, with three isolates. eBURST analysis of all the STs
from NTHi isolates published in the MLST database revealed that
75.7% (n = 53) of our invasive isolates belonged to different clonal
complexes (CC) defined by the analysis. Twenty-three isolates
belonged to the five most prevalent CC among NTHi: CC1, CC3
(n = 5 each), CC41, CC57, and CC472 (n = 3 each).
Capsulated strains, by contrast, were genetically related. All
type f isolates belonged to CC124, formed by ST124 (n = 7) and
two single locus variants (recA5 and recA43). The type b strain
belonged to CC6 (SLV ST6; recA15), while the Hie strain
belonged to ST18.
Discussion
The epidemiology of invasive H. influenzae has changed since
the introduction of the Hib conjugate vaccine for children, with
nontypeable strains being the most frequent etiological agent in
most cases of invasive Hi disease in adults. The incidence rate
observed among our adults (2.12/100,000) is similar to that
reported in the USA and in Europe [6,22,23]. As documented in
other studies the incidence of invasive Hi disease increased with
age (6.8/100,000 in patients $65 years old) [6,23].
In the pre-vaccine era, Hib was the most important cause of
invasive disease (mainly meningitis) in healthy children under 5
years of age [1,4,22]. In the United States the pre-vaccine
incidence of invasive disease in adults was 1.7 cases per 100,000
persons, with Hib being responsible for 50% of invasive diseases
due to H. influenzae [11]. In the United Kingdom the incidence
of Hib infection in adults was low (9%) and it was assumed to be a
consequence of transmission from children [24]. Since the
widespread childhood immunization program in the 1990s, Hib
infection has decreased considerably worldwide [4]. The percent-
Table 2. Antimicrobial susceptibility of 70 invasive H. influenzae.
MIC50 MIC90 Range % S % I % R
Antimicrobial (mg/L) (mg/L) (mg/L)
Ampicillina 0.25 2 #0.12–.4 85.7 4.3 10.0
Amoxicillin/clavulanic
acidb
#0.5 2 #0.5–4 100
Cefuroxime 1 2 #0.5–8 98.6 1.4
Cefepime #0.25 #0.25 #0.25–0.25 100
Cefotaxime #0.06 #0.06 #0.06–0.06 100
Ceftriaxone #0.12 #0.12 #0.12 100
Imipenem 0.5 1 #0.12–2 100
Chloramphenicol #1 #1 #1 100
Tetracycline #1 2 #1–2 100
Ciprofloxacin #0.03 #0.03 #0.03 100
Cotrimoxazolec #0.5 .2 #0.5–.2 72.9 1.4 25.7
Azithromycin 1 2 #0.12–.4 98.6 1.4
ab-lactamase production: 8.6% (n = 6).
bThe ratio of amoxicillin/clavulanic acid was 2:1.
cThe ratio of cotrimoxazole was 1:19.
doi:10.1371/journal.pone.0112711.t002
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age of Hib infection cases in adults varies depending on the region.
In Illinois, for example, 17.7% of cases were Hib, whereas in Utah
the figure was 9% [6,11]. Only one of our isolates was identified as
Hib (1.4%), a lower percentage than previously reported (4.92%)
in another Spanish study [25]. Concerning non-b capsulated
strains, Hif is currently the most frequent serotype causing invasive
disease [1,5,11,25–27]. However, despite the fact that in our
hospital the number of invasive H. influenzae isolated from 2008–
2013 remained stable, an increment in non-b capsulated strains
was observed in 2013, when the number of capsulated isolates
doubled due to an increase in serotype f.
During the pre-vaccination era, NTHi were not a frequent
cause of invasive disease, even though they had been considered
an important respiratory pathogen in adults [8]. However, a strain
shift has been observed since vaccination, with NTHi being the
strains most frequently responsible for invasive infections in adults
[1]. NTHi were the most common cause of invasive Hi infection in
adults in Illinois (34%), Utah (43%), Manitoba (57%), and Sweden
[6,11,26,27]. A recent publication in Spain reported 62% of NTHi
among invasive isolates from adults (2004–2009) [25]. In our
study, which analyzed invasive isolates from 2008 to 2013, 85.7%
of strains were identified as NTHi, following the trend observed in
other studies and adding to previously published data on more
recently isolated strains.
As reported in other studies [3,6,11], most invasive H.
influenzae disease infections occurred in older adults (n = 47
patients were $65 years old) and in those with underlying
conditions. Increased life expectancy and the growing number of
patients with underlying conditions may account for the high
proportion of invasive Hi disease found in the present study.
Pneumonia was the most common type of infection caused by
invasive H. influenzae in adults, as reported elsewhere
[10,22,24,28]. In line with other studies [3,6,11,28,29], our
patients with invasive H. influenzae infection showed a high
mortality rate, although again this could be associated with age
and underlying conditions. Nevertheless, we have to acknowledge
the small number of cases identified as a limitation of our study.
Following the clinical and epidemiological evaluation of samples
the study aimed to investigate the antimicrobial resistance of
invasive H. influenzae. Traditionally, the most common mecha-
nism of b-lactam resistance in H. influenzae has been b-lactamase
production, although this production has decreased over time [30–
32]. The percentage of b-lactamase in invasive H. influenzae
varies depending on the study, ranging from 10–24% [3,25,26,32–
38]. In our study the percentage of b-lactamase production was
8.6%, in line with published data although lower than the figures
(16.9% and 24.2%) reported in two previous studies about invasive
H. influenzae performed in 1999–2000 and 2004–2009 in Spain
[3,25]. b-lactam resistance due to alterations in PBP3 has also
been reported worldwide [18,26,30,39,40]. In the present study,
32.9% of isolates were considered gBLNAR, with ampicillin MIC
of 0.5–4 mg/L, presenting relevant mutations in the transpepti-
dase domain of ftsI. Although these mutations conferred reduced
susceptibility to ampicillin, the isolates in question were not
considered resistant according to current CLSI and EUCAST
breakpoints, the exception being one strain which presented an
ampicillin MIC of 4 mg/L. In our experience, the patients
infected by BLNAR strains were successfully treated with
amoxicillin/clavulanic acid, cefepime, ceftriaxone, piperacillin/
tazobacatam, and quinolones (data not shown). Currently, these
strains with altered MICs to b-lactams can be successfully treated
with these antibiotics; however, the detection of BLNAR strains in
the laboratory could improve the knowledge about the epidemi-
ology of H. influenzae. The most common mutations found in
invasive isolates were those that classified the strains into group IIb
(47.8%), this being consistent with previous data reported by
Resman et al., Shuel et al., and Bajanca et al. [26,33,37]. By
contrast, however, with Spanish data published by Garcı´a-Cobos
et al., who found that group IIc was the most common BLNAR
genotype in invasive H. influenzae (42.4%) [25].
Genotyping by PFGE and MLST showed a high diversity
among NTHi strains, which were distributed into three clonal
groups and 45 singletons. Despite the high genetic variability
observed in NTHi, the majority of isolates were grouped
according to the most prevalent clonal complexes defined by
eBURST, using all the NTHi published in the MLST database.
Capsulated strains, by contrast, were clonally related. These results
are consistent with other studies that also described this difference
in diversity between NTHi and capsular H. influenzae [26,33,37].
Moreover, all capsulated strains found in our study belonged to
international disseminated global clones. For instance, all nine Hif
isolates were grouped in CC124 (ST124 and two single locus
variants), which has been identified in the USA and other
European countries [25,33,37,38]. Hib and Hie isolates belonged,
respectively, to the CC6 and CC18 clones, which have been
detected worldwide (http://haemophilus.mlst.net/).
In conclusion, NTHi were the most frequent cause of invasive
Hi disease in adults, who frequently presented underlying
conditions, and they were associated with a high mortality rate.
In our hospital, however, there was an increase in capsular strains,
generally serotype f, during 2013. It should also be noted that
reduced ampicillin susceptibility was observed in a high percentage
of invasive H. influenzae due to mutations in PBP3. Despite the
reduction in Hib, continuous monitoring of invasive H. influenzae
infections should be performed, not only because of the recent
increase in capsulated non-b strains but also in order to detect
changes in the epidemiology of invasive H. influenzae.
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